Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/9973
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNagvadiya, Sahilraj-
dc.date.accessioned2021-08-16T08:28:05Z-
dc.date.available2021-08-16T08:28:05Z-
dc.date.issued2021-05-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/9973-
dc.description.abstractCancer is a disease involving cellular changes, such as abnormal cell growth, altered cell contact, and generation of cellular forces, which is due to the alteration of the cytoskeleton. A Rho-associated central coiled-coil kinase (ROCK) is a kinase associated with cancer progression and its level of expression is altered. ROCK1 and ROCK2 are the main two kinases of ROCK and are associated with cellular processes & regulation of the cytoskeleton. Multiple somatic gene mutations, as well as single nucleotide polymorphism (SNPs) of ROCK, are observed in different types of cancer. For the docking studies, protein (PDB ID: 3tku) which is having a resolution of 2.15 A° was considered. Molecules were docked using software such as AUTODOCK, AUTODOCK VINA, and PyRx. The molecule with a good docking score was followed by ADMET studies.en_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPDR00692;-
dc.subjectDissertation Reporten_US
dc.subjectPharmaceutical Chemistryen_US
dc.subjectMedicinal Chemistryen_US
dc.subject19MPHen_US
dc.subject19MPH404en_US
dc.subjectPDR00692en_US
dc.titleDesign and Synthesis of RHO Kinase Inhibitorsen_US
dc.typeDissertationen_US
Appears in Collections:M.Pharm. Research Reports, Department of Medicinal Chemistry

Files in This Item:
File Description SizeFormat 
PDR00692_19MPH404.pdfPDR006921.56 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.